Ophthalmic Drug Discovery and Development: Regulatory Aspects of Patient Focused Drug Development in Ophthalmology
Crossref DOI link: https://doi.org/10.1007/s11095-019-2577-8
Published Online: 2019-02-21
Published Print: 2019-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rowe-Rendleman, Cheryl L. http://orcid.org/0000-0002-3024-2356
Text and Data Mining valid from 2019-02-21
Article History
Received: 6 November 2018
Accepted: 17 January 2019
First Online: 21 February 2019